The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...

India’s Ministry of Health has released new guidelines to help identify respiratory viral illness symptoms. Early recognition ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

RSV infections in children needing primary care cause high economic impact due to outpatient costs and parental work absences ...

The World Health Organization (WHO) on Friday recommended all countries to use both maternal vaccine and a monoclonal antibody to protect babies against respiratory syncytial virus ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

There have been almost 50,000 cases of RSV recorded this year, but only a select group can access the free vaccine, with ...

The State Government has extended its free RSV immunisation programme for babies and young children, as WA braces for a surge ...

Last winter’s respiratory syncytial virus, or RSV, season wasn’t as brutal for U.S. babies. A new study suggests two preventive tools — a maternal vaccine and a monoclonal antibody for ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...